People around the world use Aspirin in their daily lives, whether it’s to treat fevers, inflammation, arthritis, or just general pain.
New studies would like to add to that list. Leiden University Medical Centre in the Netherlands ran a multitude of tests on those with gastrointestinal and colon cancer and found that taking Aspirin after cancer treatment often increased survivability of the individual.
Through rigorous testing post-diagnosis, Aspirin users were twice as likely to survive gastrointestinal cancer than those who didn’t take the drug.
What is unique about this number is that it was determined after taking into account confounding variables such as age, sex, cancer stage, and form of cancer treatment.
Dr. Frouws, the head of research behind this project, came forth stating that he wants to change the medicinal formula that we as a nation have come to accept. The formula we currently have is that medicine should be personalized, which leads to an extreme increase in price and a decrease in effectiveness over the general population.
Dr. Frouws thinks that we need to reverse this idea and instead of personalizing medicine, we need to take a step toward the generalization of medicine.
The benefit of a cheap, well established, and over-the-counter drug such as Aspirin is the key to treating the masses. It’s because that Aspirin isn’t a personalized drug, it can treat a larger group of people all while focusing in on the treatment of a select individual.
In today’s modern economy where the number of middle class citizens increases daily, this is a step in the right direction. There has to be a trust between government grade pharmaceuticals and the citizens of the country or infrastructure begins to falter. We see people on the news like Martin Shkreli, who bought out Turing Pharmaceuticals and raised the price of the drug Daraprim (a drug used to treat multidrug-resistant tuberculosis) from $13.50 to $750, receiving colossal backlash from the general population. We as a nation can’t have people doing that because it breaks the bridge that took years to set up which is why this study done by the Leiden University Medical Centre in the Netherlands is so vital to the progression of medicinal science.